世界の慢性うつ病性人格障害の治療市場:販売動向2019

QYResearchが発行した調査報告書(DATA907A2076)
◆英語タイトル:Global Chronic Depressive Personality Disorder Treatment Sales Market Report 2019
◆商品コード:DATA907A2076
◆発行会社(リサーチ会社):QYResearch
◆発行日:2019年8月(※2024年版があります。お問い合わせください。)
◆ページ数:103
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥1,184,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、慢性うつ病性人格障害の治療の世界市場について調査・分析し、慢性うつ病性人格障害の治療のメーカー別販売量、市場シェア分析、種類別販売分析(選択的セロトニン再取り込み阻害薬、三環系抗うつ薬、ノルアドレナリン再取り込み阻害薬)、用途別販売分析(Hospital Pharmacy、Retail Pharmacy、Online Pharmacy)、地域別販売分析(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)、価格動向、企業動向、市場規模予測などを含め、以下の構成でお届けいたします。

・慢性うつ病性人格障害の治療市場概要
・慢性うつ病性人格障害の治療のメーカー別販売量・メーカー別シェア
・慢性うつ病性人格障害の治療の種類別販売量(選択的セロトニン再取り込み阻害薬、三環系抗うつ薬、ノルアドレナリン再取り込み阻害薬)
・慢性うつ病性人格障害の治療の用途別販売量(Hospital Pharmacy、Retail Pharmacy、Online Pharmacy)
・慢性うつ病性人格障害の治療の地域別販売量・市場シェア
・慢性うつ病性人格障害の治療のアメリカ市場規模(2014年-2019年)
・慢性うつ病性人格障害の治療のヨーロッパ市場規模(2014年-2019年)
・慢性うつ病性人格障害の治療の中国市場規模(2014年-2019年)
・慢性うつ病性人格障害の治療の日本市場規模(2014年-2019年)
・慢性うつ病性人格障害の治療の東南アジア市場規模(2014年-2019年)
・慢性うつ病性人格障害の治療のインド市場規模(2014年-2019年)
・慢性うつ病性人格障害の治療メーカー分析(企業概要、製品概要、販売量、売上、価格等)
・慢性うつ病性人格障害の治療のコスト分析
・慢性うつ病性人格障害の治療販売チャネル、流通業者、顧客
・慢性うつ病性人格障害の治療の世界市場動向・機会・成長要因・課題
・慢性うつ病性人格障害の治療の種類別世界市場予測(選択的セロトニン再取り込み阻害薬、三環系抗うつ薬、ノルアドレナリン再取り込み阻害薬)
・慢性うつ病性人格障害の治療の用途別世界市場予測(Hospital Pharmacy、Retail Pharmacy、Online Pharmacy)
・慢性うつ病性人格障害の治療のアメリカ市場予測(2019年-2025年)
・慢性うつ病性人格障害の治療のヨーロッパ市場予測(2019年-2025年)
・慢性うつ病性人格障害の治療の中国市場予測(2019年-2025年)
・慢性うつ病性人格障害の治療の日本市場予測(2019年-2025年)
・慢性うつ病性人格障害の治療の東南アジア市場予測(2019年-2025年)
・慢性うつ病性人格障害の治療のインド市場予測(2019年-2025年)
...
【レポートの概要】

Chronic depressive personality disorder also known as Dysthymia is a chronic form of depression. It is mild form of depression which last up to two years or more. This disorder is less severe in comparison to other forms of depression. Symptoms of chronic depressive personality disorder are loss of interest in daily activities, sadness, tiredness, trouble in concentrating and decision making, suicidal thoughts, and some others. Medication and psychotherapy are used for the management of chronic depressive personality disorder. Psychotherapy is preferred for children and adolescents instead of medication. But it also depend upon the severity of the chronic depressive personality disorder. Changing the lifestyle can also help in management of this disorder.Chronic depressive personality disorder treatment market is expected driven by increasing prevalence and increasing diagnosis. Chronic depressive personality disorder is a chronic disorder as suggested by the name which require a long term treatment measures. Requirement for long term treatment is also expected to drive the growth of this market. Government initiatives and awareness programs are also expected to fuel the growth of chronic depressive personality disorder treatment market. Effectiveness of psychotherapy alone and non-medicated treatment option can be restraint in the growth of medicated chronic depressive personality disorder treatment market.

The global Chronic Depressive Personality Disorder Treatment market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report studies the global Chronic Depressive Personality Disorder Treatment market status and forecast, categorizes the global Chronic Depressive Personality Disorder Treatment market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Major manufacturers covered in this report
Eli Lilly
Forest Laboratories
GlaxoSmithKline
Merck Sharp & Dohme
Pfizer
Allergan
Novartis

In view of regional level, this report covers
United States
Europe
China
Japan
Southeast Asia
India

Segment by Type
Selective Serotonin Reuptake Inhibitors
Tricyclic Antidepressants
Norepinephrine Reuptake Inhibitors
Others

Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

【レポートの目次】

Table of Contents

Global Chronic Depressive Personality Disorder Treatment Sales Market Report 2019
1 Chronic Depressive Personality Disorder Treatment Market Overview
1.1 Chronic Depressive Personality Disorder TreatmentProduct Overview
1.2 Chronic Depressive Personality Disorder Treatment Segment by Type
1.2.1 Global Chronic Depressive Personality Disorder Treatment Sales Comparison by Types (2014-2025)
1.2.2 Selective Serotonin Reuptake Inhibitors
1.2.3 Tricyclic Antidepressants
1.2.4 Norepinephrine Reuptake Inhibitors
1.2.5 Others
1.3 Chronic Depressive Personality Disorder Treatment Segment by Application
1.3.1 Global Chronic Depressive Personality Disorder Treatment Sales Comparison by Application (2014-2025)
1.3.1 Hospital Pharmacy
1.3.2 Retail Pharmacy
1.3.3 Online Pharmacy
1.4 Chronic Depressive Personality Disorder Treatment Market by Region
1.4.1 Global Chronic Depressive Personality Disorder Treatment Revenue Comparison by Region (2014-2025)
1.4.2 United States Chronic Depressive Personality Disorder Treatment Status and Prospect (2014-2025)
1.4.3 Europe Chronic Depressive Personality Disorder Treatment Status and Prospect (2014-2025)
1.4.4 China Chronic Depressive Personality Disorder Treatment Status and Prospect (2014-2025)
1.4.5 Japan Chronic Depressive Personality Disorder Treatment Status and Prospect (2014-2025)
1.4.6 Southeast Asia Chronic Depressive Personality Disorder Treatment Status and Prospect (2014-2025)
1.4.7 India Chronic Depressive Personality Disorder Treatment Status and Prospect (2014-2025)
1.5 Global Chronic Depressive Personality Disorder Treatment Sales and Revenue (2014-2025)
1.5.1 Global Chronic Depressive Personality Disorder Treatment Sales and Growth Rate (2014-2025)
1.5.2 Global Chronic Depressive Personality Disorder Treatment Revenue and Growth Rate (2014-2025)

2 Chronic Depressive Personality Disorder Treatment by Company, Region, Type and Application
2.1 Global Chronic Depressive Personality Disorder Treatment Market Competition by Companies
2.1.1 Global Chronic Depressive Personality Disorder Treatment Sales Market Share of Key Companies (2014-2019)
2.1.2 Global Chronic Depressive Personality Disorder Treatment Revenue Market Share by Company (2014-2019)
2.2 Global Chronic Depressive Personality Disorder Treatment Sales and Revenue by Region
2.2.1 Global Chronic Depressive Personality Disorder Treatment Sales Market Share by Region (2014-2019)
2.2.2 Global Chronic Depressive Personality Disorder Treatment Revenue Market Share by Region (2014-2019)
2.3 Global Chronic Depressive Personality Disorder Treatment Sales and Revenue by Type
2.3.1 Global Chronic Depressive Personality Disorder Treatment Sales Market Share by Type (2014-2019)
2.3.2 Global Chronic Depressive Personality Disorder Treatment Revenue Market Share by Type (2014-2019)
2.4 Global Chronic Depressive Personality Disorder Treatment Sales by Application

3 United States Chronic Depressive Personality Disorder Treatment Sales, Revenue and Price
3.1 United States Chronic Depressive Personality Disorder Treatment Sales and Revenue (2014-2019)
3.1.1 United States Chronic Depressive Personality Disorder Treatment Sales Growth Rate (2014-2019)
3.1.2 United States Chronic Depressive Personality Disorder Treatment Revenue Growth Rate (2014-2019)
3.1.3 United States Chronic Depressive Personality Disorder Treatment Price Trend (2014-2019)
3.2 United States Chronic Depressive Personality Disorder Treatment Sales Market Share by Company
3.3 United States Chronic Depressive Personality Disorder Treatment Sales Market Share by Type
3.4 United States Chronic Depressive Personality Disorder Treatment Sales Market Share by Application

4 Europe Chronic Depressive Personality Disorder Treatment Sales, Revenue and Price
4.1 Europe Chronic Depressive Personality Disorder Treatment Sales and Value (2014-2019)
4.1.1 Europe Chronic Depressive Personality Disorder Treatment Sales Growth Rate (2014-2019)
4.1.2 Europe Chronic Depressive Personality Disorder Treatment Revenue Growth Rate (2014-2019)
4.1.3 Europe Chronic Depressive Personality Disorder Treatment Price Trend (2014-2019)
4.2 Europe Chronic Depressive Personality Disorder Treatment Sales Market Share by Company
4.3 Europe Chronic Depressive Personality Disorder Treatment Sales Market Share by Type
4.4 Europe Chronic Depressive Personality Disorder Treatment Sales Market Share by Application

5 China Chronic Depressive Personality Disorder Treatment Sales, Revenue and Price
5.1 China Chronic Depressive Personality Disorder Treatment Sales and Revenue (2014-2019)
5.1.1 China Chronic Depressive Personality Disorder Treatment Sales Growth Rate (2014-2019)
5.1.2 China Chronic Depressive Personality Disorder Treatment Revenue Growth Rate (2014-2019)
5.1.3 China Chronic Depressive Personality Disorder Treatment Price Trend (2014-2019)
5.2 China Chronic Depressive Personality Disorder Treatment Sales Market Share by Company
5.3 China Chronic Depressive Personality Disorder Treatment Sales Market Share by Type
5.4 China Chronic Depressive Personality Disorder Treatment Sales Market Share by Application

6 Japan Chronic Depressive Personality Disorder Treatment Sales, Revenue and Price
6.1 Japan Chronic Depressive Personality Disorder Treatment Sales and Value (2014-2019)
6.1.1 Japan Chronic Depressive Personality Disorder Treatment Sales Growth Rate (2014-2019)
6.1.2 Japan Chronic Depressive Personality Disorder Treatment Revenue Growth Rate (2014-2019)
6.1.3 Japan Chronic Depressive Personality Disorder Treatment Price Trend (2014-2019)
6.2 Japan Chronic Depressive Personality Disorder Treatment Sales Market Share by Company
6.3 Japan Chronic Depressive Personality Disorder Treatment Sales Market Share by Type
6.4 Japan Chronic Depressive Personality Disorder Treatment Sales Market Share by Application

7 Southeast Asia Chronic Depressive Personality Disorder Treatment Sales, Revenue and Price
7.1 Southeast Asia Chronic Depressive Personality Disorder Treatment Sales and Value (2014-2019)
7.1.1 Southeast Asia Chronic Depressive Personality Disorder Treatment Sales Growth Rate (2014-2019)
7.1.2 Southeast Asia Chronic Depressive Personality Disorder Treatment Revenue Growth Rate (2014-2019)
7.1.3 Southeast Asia Chronic Depressive Personality Disorder Treatment Price Trend (2014-2019)
7.2 Southeast Asia Chronic Depressive Personality Disorder Treatment Sales Market Share by Company
7.3 Southeast Asia Chronic Depressive Personality Disorder Treatment Sales Market Share by Type
7.4 Southeast Asia Chronic Depressive Personality Disorder Treatment Sales Market Share by Application

8 India Chronic Depressive Personality Disorder Treatment Sales, Revenue and Price
8.1 India Chronic Depressive Personality Disorder Treatment Sales and Value (2014-2019)
8.1.1 India Chronic Depressive Personality Disorder Treatment Sales Growth Rate (2014-2019)
8.1.2 India Chronic Depressive Personality Disorder Treatment Revenue Growth Rate (2014-2019)
8.1.3 India Chronic Depressive Personality Disorder Treatment Price Trend (2014-2019)
8.2 India Chronic Depressive Personality Disorder Treatment Sales Market Share by Company
8.3 India Chronic Depressive Personality Disorder Treatment Sales Market Share by Type
8.4 India Chronic Depressive Personality Disorder Treatment Sales Market Share by Application

9 Company Profiles and Key Figures in Chronic Depressive Personality Disorder Treatment Business
9.1 Eli Lilly
9.1.1 Eli Lilly Chronic Depressive Personality Disorder Treatment Production Sites and Area Served
9.1.2 Chronic Depressive Personality Disorder Treatment Specification and Application
9.1.3 Eli Lilly Chronic Depressive Personality Disorder Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.1.4 Main Business and Markets Served
9.2 Forest Laboratories
9.2.1 Forest Laboratories Chronic Depressive Personality Disorder Treatment Production Sites and Area Served
9.2.2 Chronic Depressive Personality Disorder Treatment Specification and Application
9.2.3 Forest Laboratories Chronic Depressive Personality Disorder Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.2.4 Main Business and Markets Served
9.3 GlaxoSmithKline
9.3.1 GlaxoSmithKline Chronic Depressive Personality Disorder Treatment Production Sites and Area Served
9.3.2 Chronic Depressive Personality Disorder Treatment Specification and Application
9.3.3 GlaxoSmithKline Chronic Depressive Personality Disorder Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.3.4 Main Business and Markets Served
9.4 Merck Sharp & Dohme
9.4.1 Merck Sharp & Dohme Chronic Depressive Personality Disorder Treatment Production Sites and Area Served
9.4.2 Chronic Depressive Personality Disorder Treatment Specification and Application
9.4.3 Merck Sharp & Dohme Chronic Depressive Personality Disorder Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.4.4 Main Business and Markets Served
9.5 Pfizer
9.5.1 Pfizer Chronic Depressive Personality Disorder Treatment Production Sites and Area Served
9.5.2 Chronic Depressive Personality Disorder Treatment Specification and Application
9.5.3 Pfizer Chronic Depressive Personality Disorder Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.5.4 Main Business and Markets Served
9.6 Allergan
9.6.1 Allergan Chronic Depressive Personality Disorder Treatment Production Sites and Area Served
9.6.2 Chronic Depressive Personality Disorder Treatment Specification and Application
9.6.3 Allergan Chronic Depressive Personality Disorder Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.6.4 Main Business and Markets Served
9.7 Novartis
9.7.1 Novartis Production Sites and Area Served
9.7.2 Chronic Depressive Personality Disorder Treatment Specification and Application
9.7.3 Novartis Chronic Depressive Personality Disorder Treatment Sales, Revenue, Price and Gross Margin (2014-2019)
9.7.4 Main Business and Markets Served

10 Chronic Depressive Personality Disorder Treatment Maufacturing Cost Analysis
10.1 Chronic Depressive Personality Disorder Treatment Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Key Raw Materials Price Trend
10.1.3 Key Suppliers of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.3 Manufacturing Process Analysis of Chronic Depressive Personality Disorder Treatment
10.4 Chronic Depressive Personality Disorder Treatment Industrial Chain Analysis

11 Marketing Channel, Distributors and Customers
11.1 Marketing Channel
11.1.1 Direct Marketing
11.1.2 Indirect Marketing
11.2 Chronic Depressive Personality Disorder Treatment Distributors List
11.3 Chronic Depressive Personality Disorder Treatment Customers

12 Market Dynamics
12.1 Market Trends
12.2 Opportunities
12.3 Market Drivers
12.4 Challenges
12.5 Influence Factors

13 Chronic Depressive Personality Disorder Treatment Market Forecast
13.1 Global Chronic Depressive Personality Disorder Treatment Sales, Revenue and Price Forecast
13.1.1 Global Chronic Depressive Personality Disorder Treatment Sales Growth Forecast (2019-2025)
13.1.2 Global Chronic Depressive Personality Disorder Treatment Revenue Growth Forecast (2019-2025)
13.1.3 Global Chronic Depressive Personality Disorder Treatment Price Trend Forecast (2019-2025)
13.2 Global Chronic Depressive Personality Disorder Treatment Forecast by Region
13.2.1 Global Chronic Depressive Personality Disorder Treatment Sales Growth Forecast by Region (2019-2025)
13.2.2 Global Chronic Depressive Personality Disorder Treatment Revenue Growth Forecast by Region (2019-2025)
13.2.3 United States Chronic Depressive Personality Disorder Treatment Sales, Revenue Growth Forecast (2019-2025)
13.2.4 Europe Chronic Depressive Personality Disorder Treatment Sales, Revenue Growth Forecast (2019-2025)
13.2.5 China Chronic Depressive Personality Disorder Treatment Sales, Revenue Growth Forecast (2019-2025)
13.2.6 Japan Chronic Depressive Personality Disorder Treatment Sales, Revenue Growth Forecast (2019-2025)
13.2.7 Southeast Asia Chronic Depressive Personality Disorder Treatment Sales, Revenue Growth Forecast (2019-2025)
13.2.8 India Chronic Depressive Personality Disorder Treatment Sales, Revenue Growth Forecast (2019-2025)
13.3 Global Chronic Depressive Personality Disorder Treatment Forecast by Type
13.3.1 Global Chronic Depressive Personality Disorder Treatment Sales Forecast by Type (2019-2025)
13.3.2 Global Chronic Depressive Personality Disorder Treatment Revenue Forecast by Type (2019-2025)
13.3.3 Global Chronic Depressive Personality Disorder Treatment Price Forecast by Type (2019-2025)
13.4 Global Chronic Depressive Personality Disorder Treatment Forecast by Application

14 Research Findings and Conclusion

15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の慢性うつ病性人格障害の治療市場:販売動向2019(Global Chronic Depressive Personality Disorder Treatment Sales Market Report 2019)]についてメールでお問い合わせはこちらでお願いします。